CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients
It is demonstrated in vitro that CRISPR can be used to excise the HTLV-1 genome and reduce proviral loads in PBMCs from HAM/TSP patients and may serve as a platform for curing HAM/TSP.
Samuel Brancazio, K. Khalili, Steven Jacobson et al.
· Journal of Neurovirology · 0 citations